Johnson & Johnson names ex-Sanofi executive as pharma, R&D vice president

Reuters

Published Feb 13, 2023 05:20PM ET

(Reuters) - Johnson & Johnson (NYSE:JNJ) said on Monday John Reed will take the role of executive vice president of pharmaceuticals, research and development, effective April 3.